115 related articles for article (PubMed ID: 9489481)
1. How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone?
Taubert H; Berger D; Hinze R; Meye A; Würl P; Hogendoorn PC; Holzhausen HJ; Schmidt H; Rath FW
Cancer Lett; 1998 Jan; 123(2):147-51. PubMed ID: 9489481
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
3. [Detection of point mutation of p53 gene by silver staining PCR-SSCP in paraffin-embedded malignant fibrous histiocytoma].
Li J; Yang G; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):13-5. PubMed ID: 8732103
[TBL] [Abstract][Full Text] [Related]
4. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
5. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutations in osteosarcomas of low-grade malignancy.
Radig K; Schneider-Stock R; Haeckel C; Neumann W; Roessner A
Hum Pathol; 1998 Nov; 29(11):1310-6. PubMed ID: 9824113
[TBL] [Abstract][Full Text] [Related]
7. Analysis of central regulatory pathways in p53-deficient primary cultures of malignant fibrous histiocytoma exposed to ifosfamide.
Schlott T; Taubert H; Fayyazi A; Schweyer S; Bartel F; Korabiowska M; Brinck U
Anticancer Res; 2004; 24(6):3819-29. PubMed ID: 15736417
[TBL] [Abstract][Full Text] [Related]
8. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas.
Taubert H; Würl P; Meye A; Berger D; Thamm B; Neumann K; Hinze R; Schmidt H; Rath FW
Cancer; 1995 Oct; 76(7):1187-96. PubMed ID: 8630896
[TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
11. Malignant fibrous histiocytoma of the pancreas: a case report with genetic analysis.
Bastian D; Ramaswamy A; Barth PJ; Gerdes B; Ernst M; Bartsch D
Cancer; 1999 Jun; 85(11):2352-8. PubMed ID: 10357405
[TBL] [Abstract][Full Text] [Related]
12. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas.
Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T
Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365
[TBL] [Abstract][Full Text] [Related]
13. Infrequent genetic alterations of p53, p16 genes and polymorphism in fhit gene in Indian myelodysplastic syndrome.
Kannan K; Tharu R; Gopinath PM; Bharadwaj TP; Munirajan AK; Tsuchida N; Shanmugam G
Oncol Res; 1999; 11(2):101-4. PubMed ID: 10489166
[TBL] [Abstract][Full Text] [Related]
14. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
[TBL] [Abstract][Full Text] [Related]
15. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.
Orlow I; Drobnjak M; Zhang ZF; Lewis J; Woodruff JM; Brennan MF; Cordon-Cardo C
J Natl Cancer Inst; 1999 Jan; 91(1):73-9. PubMed ID: 9890173
[TBL] [Abstract][Full Text] [Related]
16. Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues.
Asp J; Sangiorgi L; Inerot SE; Lindahl A; Molendini L; Benassi MS; Picci P
Int J Cancer; 2000 Mar; 85(6):782-6. PubMed ID: 10709095
[TBL] [Abstract][Full Text] [Related]
17. Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p.
Sabah M; Cummins R; Leader M; Kay E
Virchows Arch; 2005 Mar; 446(3):251-8. PubMed ID: 15731925
[TBL] [Abstract][Full Text] [Related]
18. Predominant p53 G-->A transition mutation and enhanced cell proliferation in uterine sarcomas of CBA mice treated with 1,2-dimethylhydrazine.
Trukhanova LS; Hong HH; Sills RC; Bowser AD; Gaul B; Boorman GA; Turusov VS; Devereux TR; Dixon D
Toxicol Pathol; 1998; 26(3):367-74. PubMed ID: 9608642
[TBL] [Abstract][Full Text] [Related]
19. p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumours.
Jaffrain-Rea ML; Ferretti E; Toniato E; Cannita K; Santoro A; Di Stefano D; Ricevuto E; Maroder M; Tamburrano G; Cantore G; Gulino A; Martinotti S
Clin Endocrinol (Oxf); 1999 Sep; 51(3):317-25. PubMed ID: 10469011
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]